Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05947838
What this trial is testing

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Who this might be right for
Appendiceal AdenocarcinomaColorectal
M.D. Anderson Cancer Center 48
Not applicableEnded earlyNCT00942058
What this trial is testing

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Centre Hospitalier Universitaire de Saint Etienne 16
Not applicableStudy completedNCT01597258
What this trial is testing

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 2,029
Not applicableStudy completedNCT02206048
What this trial is testing

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

Who this might be right for
Cervix Carcinoma
M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT01233843
What this trial is testing

Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

Who this might be right for
Squamous Cell Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 370
Large-scale testing (Phase 3)UnknownNCT03779035
What this trial is testing

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Tianjin Medical University Cancer Institute and Hospital 460
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Very early researchUnknownNCT04048317
What this trial is testing

Effectiveness of Drug Eluting TACE in Primary HCC

Who this might be right for
Hepatic Cell Carcinoma
Assiut University 75
Early research (Phase 1)Study completedNCT02639117
What this trial is testing

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
University of Arizona 4
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Testing effectiveness (Phase 2)Study completedNCT01152840
What this trial is testing

Study of RAD001 in Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic Carcinoma
Seoul National University Hospital 33
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Not applicableUnknownNCT02951897
What this trial is testing

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma, Stage IDiagnoses DiseasesCirculating Tumor Cells+1 more
Third Military Medical University 120
Testing effectiveness (Phase 2)Study completedNCT04264260
What this trial is testing

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

Who this might be right for
Hepatocellular Carcinoma Stage IIIBCholangiocarcinoma, IntrahepaticCholangiocarcinoma; With Hepatocellular Carcinoma+1 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 42
Large-scale testing (Phase 3)Study completedNCT00440414
What this trial is testing

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 320
Testing effectiveness (Phase 2)Study completedNCT04518852
What this trial is testing

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsDigestive System Neoplasms+5 more
Sichuan Cancer Hospital and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35
Large-scale testing (Phase 3)Study completedNCT00035152
What this trial is testing

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 444
Not applicableStudy completedNCT00641238
What this trial is testing

Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
State University of New York - Upstate Medical University 20
Next Page